Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2006
08/10/2006WO2006081826A2 Survivin peptide vaccine
08/10/2006WO2006081718A1 Kit and method for the detection of anti-hepatitis c virus (hcv) antibodies
08/10/2006WO2006081609A1 Molecules and chimeric molecules thereof
08/10/2006WO2006069727A3 Synthesis of peptide t-20 using peptide intermediate fragments
08/10/2006WO2006067565A3 Truncated gabab receptor and methods of use thereof
08/10/2006WO2006064378A3 Adjuvant activity of gastrointestinal peptides
08/10/2006WO2006059130A9 Manipulation of starch granule size and number (ii)
08/10/2006WO2006059081A3 Methods of treatment using melanopsin
08/10/2006WO2006059069A3 Ion channel
08/10/2006WO2006055331A3 Porcine reproductive and respiratory syndrome virus strains and compositions
08/10/2006WO2006042145A3 THE RICE BACTERIAL BLIGHT DISEASE RESISTANCE GENE xa5
08/10/2006WO2006029632A3 Chimeric phage-derived particles, methods for their production and use
08/10/2006WO2006027147A3 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr)
08/10/2006WO2006018418A3 Antiangiogenic peptides
08/10/2006WO2006017386A3 Signaling intermediates in an in vitro model of alzheimer’s disease
08/10/2006WO2006005585A3 Secreted polypeptide species differentially expressed during pregnancy
08/10/2006WO2005122739A3 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus
08/10/2006WO2005121376A3 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant
08/10/2006WO2005117944A3 Hsp20 inhibits amyloidogenesis and neurotoxicity
08/10/2006WO2005110493A3 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
08/10/2006WO2005100573A3 Fungal promoters for expressing a gene in a fungal cell
08/10/2006WO2005099337A3 Therapeutic peptides
08/10/2006WO2005086663A3 Polypeptides for inducing a protective immune response against staphlococcus aureus
08/10/2006WO2005085280A3 HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
08/10/2006WO2005084190A3 Methods and compostions for targeted cleavage and recombination
08/10/2006WO2005069724A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
08/10/2006WO2005017101A3 Avian adenoassociated virus (aaav) and uses thereof
08/10/2006WO2005001417A3 Crystals of hepatitis c virus polymerase and/or hepatitis c virus polymerase-like proteins and the use thereof
08/10/2006WO2004087886A3 Modified adenoviral e1a constructs and methods of use thereof
08/10/2006WO2003074004A3 Method of producing antigens
08/10/2006WO2003065999A3 Proliferated cell lines and uses thereof
08/10/2006US20060179518 Plant proteins having an abscisic acid binding site and methods of use
08/10/2006US20060179517 The rice restorer gene to the rice bt type cytoplasmic male sterility
08/10/2006US20060179515 Sugar and Lipid Metabolism Regulators in Plants
08/10/2006US20060179501 Transgenic mice expressing human cd20
08/10/2006US20060179496 Nucleic acid sequences differentially expressed in cancer tissue
08/10/2006US20060179493 Transgenically produced non-secreted proteins
08/10/2006US20060178506 Amino acid modified polypeptides
08/10/2006US20060178505 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
08/10/2006US20060178504 Eotaxin: eosinophil chemotactic cytokine
08/10/2006US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof
08/10/2006US20060178502 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
08/10/2006US20060178501 PYY agonists and use thereof
08/10/2006US20060178337 Method for diagnosing aplasia of corpus callosum
08/10/2006US20060178317 Methods of increasing endogenous erythropoietin (EPO)
08/10/2006US20060178316 Methods of increasing endogenous erythropoietin (EPO)
08/10/2006US20060178311 Control of lactation
08/10/2006US20060178309 Method for the crystallization of human serum albumin
08/10/2006US20060178308 Complement inhibitor
08/10/2006US20060178303 Potassium channel blockers
08/10/2006US20060178302 Amyloid beta protein (globular assembly and uses thereof)
08/10/2006US20060178301 Albumin-fused ciliary neurotrophic factor
08/10/2006US20060178300 Heterocarpine, a plant-derived protein with anti-cancer properties
08/10/2006US20060178299 Therapeutic epitopes and uses thereof
08/10/2006US20060178293 Cardiotonic polypeptides
08/10/2006US20060178292 Methods and compositions of ecdysozoan molt inhibition
08/10/2006US20060177933 Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing
08/10/2006US20060177932 Expansion agents for stem cells
08/10/2006US20060177929 Regulation of self-renewal in stem cells
08/10/2006US20060177912 Nucleotide sequences which code for the dep34 gene
08/10/2006US20060177908 Il-2 transmembrane construct
08/10/2006US20060177907 Methods and materials for characterizing and modulating interaction between heregulin and HER3
08/10/2006US20060177906 IGF-I responsive gene and use thereof
08/10/2006US20060177904 Nucleotide sequences coding protein factors for use in identifying modulators for diagnosis, treatment and prevention of cell proliferative, metabolic, inflammatory, nervous system and immune disorders
08/10/2006US20060177903 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
08/10/2006US20060177902 mammalian cytokine receptor proteins with affinity for IL-13; allergic conditions, asthma, immune complex disease; lupus, nephrotic syndrome, nephritis, glomerulonephritis, thyroiditis and Grave's disease
08/10/2006US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
08/10/2006US20060177900 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
08/10/2006US20060177899 for diagnosis and treatment in receptor-mediated disorders, specifically, cardiovascular diseases, including congestive heart failure
08/10/2006US20060177897 PR1550 polypeptides and nucleic acids encoding the same
08/10/2006US20060177896 Anti-CD3 antibodies and methods of use thereof
08/10/2006US20060177895 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA polymerase and thereby prevent the assembly of a poised transcriptional complex
08/10/2006US20060177894 Protein knobs
08/10/2006US20060177872 Using paramagnetic microparticles coated with a purified recombinant porcine intrinsic factor and chemiluminescence as capture and visualization tools in detection and quantification of vitamin B12 in sample
08/10/2006US20060177871 Murine IL-18 crystal structure
08/10/2006US20060177866 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/10/2006US20060177861 Novel compositions and methods in cancer associated with altered expression of MCM3AP
08/10/2006US20060177854 Hereditary hemochromatosis gene
08/10/2006US20060177831 c-MET kinase binding proteins
08/10/2006US20060177823 Molecules
08/10/2006US20060177822 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
08/10/2006US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity
08/10/2006US20060177492 Collagen gel and process of producing the same
08/10/2006US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4
08/10/2006US20060177469 Non-toxic mucosal adjuvant
08/10/2006US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/10/2006US20060177465 Polypeptide antigens of streptococcus pneumoniae pathogen useful as vaccine for prophylaxis, diagnostic or treatment of streptococcal infection
08/10/2006US20060177464 Methods and compositions involving LcrV proteins
08/10/2006US20060177463 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide
08/10/2006US20060177462 Polypeptides for inducing a protective immune response against staphylococcus aureus
08/10/2006US20060177461 Stress proteins and uses therefor
08/10/2006US20060177460 Administering to a patient a stress protein joined via a peptide bond to a melanoma antigen to induce or enhanc an immune response against the melanoma antigen
08/10/2006US20060177457 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
08/10/2006US20060177456 Apo-2 receptor antibodies
08/10/2006US20060177451 Binding molecules for the treatment of myeloid cell malignancies
08/10/2006US20060177450 isolated mammalian nucleic acid molecule; antibody; suppressing or modulating metastatic ability of prostate tumor cells, prostate tumor growth or elimination of prostate tumor cells; antitumor agents; gene expression inhbition
08/10/2006US20060177449 Antibody and use thereof
08/10/2006US20060177443 Integrin antagonists
08/10/2006US20060177432 Methods and reagents for protease inhibition
08/10/2006US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders